Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

The vaccines consistency approach project: an EPAA initiative.

De Mattia F, Hendriksen C, Buchheit KH, Chapsal JM, Halder M, Lambrigts D, Redhead K, Rommel E, Scharton-Kersten T, Sesardic T, Viviani L, Ragan I.

Pharmeur Bio Sci Notes. 2015;2015:30-56.

PMID:
26830158
2.

Advances in vaccine delivery: transcutaneous immunisation.

Glenn GM, Scharton-Kersten T, Alving CR.

Expert Opin Investig Drugs. 1999 Jun;8(6):797-805.

PMID:
15992132
3.

Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.

Yu J, Cassels F, Scharton-Kersten T, Hammond SA, Hartman A, Angov E, Corthésy B, Alving C, Glenn G.

Infect Immun. 2002 Mar;70(3):1056-68.

4.

Transcutaneous immunization of domestic animals: opportunities and challenges.

Hammond SA, Tsonis C, Sellins K, Rushlow K, Scharton-Kersten T, Colditz I, Glenn GM.

Adv Drug Deliv Rev. 2000 Sep 15;43(1):45-55. Review.

PMID:
10967220
5.

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants.

Scharton-Kersten T, Yu Jm, Vassell R, O'Hagan D, Alving CR, Glenn GM.

Infect Immun. 2000 Sep;68(9):5306-13.

6.

Principles of transcutaneous immunization using cholera toxin as an adjuvant.

Scharton-Kersten T, Glenn GM, Vassell R, Yu J, Walwender D, Alving CR.

Vaccine. 1999 Oct 1;17 Suppl 2:S37-43.

PMID:
10506407
7.

Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms.

Walker PS, Scharton-Kersten T, Krieg AM, Love-Homan L, Rowton ED, Udey MC, Vogel JC.

Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6970-5.

8.

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.

Glenn GM, Scharton-Kersten T, Vassell R, Matyas GR, Alving CR.

Infect Immun. 1999 Mar;67(3):1100-6.

9.

The role of dendritic cells in the initiation of host resistance to Toxoplasma gondii.

Sher A, Hieny S, Charest H, Scharton-Kersten T, Collazo C, Germain RN, Reis e Sousa C.

Adv Exp Med Biol. 1998;452:103-10. Review. No abstract available.

PMID:
9889964
10.

Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.

Glenn GM, Scharton-Kersten T, Vassell R, Mallett CP, Hale TL, Alving CR.

J Immunol. 1998 Oct 1;161(7):3211-4.

11.

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.

Walker PS, Scharton-Kersten T, Rowton ED, Hengge U, Bouloc A, Udey MC, Vogel JC.

Hum Gene Ther. 1998 Sep 1;9(13):1899-907.

PMID:
9741428
12.

Partially protective vaccination permits the development of latency in a normally virulent strain of Toxoplasma gondii.

Yap GS, Scharton-Kersten T, Ferguson DJ, Howe D, Suzuki Y, Sher A.

Infect Immun. 1998 Sep;66(9):4382-8.

13.

Cytokines as determinants of disease and disease interactions.

Sher A, Gazzinelli RT, Jankovic D, Scharton-Kersten T, Yap G, Doherty TM, Wynn T.

Braz J Med Biol Res. 1998 Jan;31(1):85-7. Review.

PMID:
9686183
14.
17.

Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture.

Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K, Siebenlist U.

J Exp Med. 1998 Jan 19;187(2):147-59.

18.

In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas.

Reis e Sousa C, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN, Sher A.

J Exp Med. 1997 Dec 1;186(11):1819-29.

19.

Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo.

Wynn TA, Morawetz R, Scharton-Kersten T, Hieny S, Morse HC 3rd, Kühn R, Müller W, Cheever AW, Sher A.

J Immunol. 1997 Nov 15;159(10):5014-23.

PMID:
9366429
20.

Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response.

Hondowicz BD, Scharton-Kersten TM, Jones DE, Scott P.

J Immunol. 1997 Nov 15;159(10):5024-31.

PMID:
9366430
21.

Mechanisms of innate resistance to Toxoplasma gondii infection.

Alexander J, Scharton-Kersten TM, Yap G, Roberts CW, Liew FY, Sher A.

Philos Trans R Soc Lond B Biol Sci. 1997 Sep 29;352(1359):1355-9. Review.

23.

Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii.

Denkers EY, Yap G, Scharton-Kersten T, Charest H, Butcher BA, Caspar P, Heiny S, Sher A.

J Immunol. 1997 Aug 15;159(4):1903-8.

PMID:
9257855
24.
25.

Immune responses in mice deficient in Ly-GDI, a lymphoid-specific regulator of Rho GTPases.

Yin L, Schwartzberg P, Scharton-Kersten TM, Staudt L, Lenardo M.

Mol Immunol. 1997 Apr;34(6):481-91.

PMID:
9307064
26.

Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions.

Franzoso G, Carlson L, Scharton-Kersten T, Shores EW, Epstein S, Grinberg A, Tran T, Shacter E, Leonardi A, Anver M, Love P, Sher A, Siebenlist U.

Immunity. 1997 Apr;6(4):479-90.

27.

Role of natural killer cells in innate resistance to protozoan infections.

Scharton-Kersten TM, Sher A.

Curr Opin Immunol. 1997 Feb;9(1):44-51. Review.

PMID:
9039777
28.
29.

In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.

Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT, Sher A.

J Immunol. 1996 Nov 1;157(9):4045-54.

PMID:
8892638
30.

The role of IL-12 in regulation of T helper cell subsets in vivo. Lessons from experimental cutaneous leishmaniasis.

Scott P, Hondowicz B, Eaton A, Scharton-Kersten T.

Ann N Y Acad Sci. 1996 Oct 31;795:250-6. No abstract available.

PMID:
8958936
31.

In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.

Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R, Müller W, Trinchieri G, Sher A.

J Immunol. 1996 Jul 15;157(2):798-805.

PMID:
8752931
33.

Role of IL12 in induction of cell-mediated immunity to Toxoplasma gondii.

Scharton-Kersten T, Denkers EY, Gazzinelli R, Sher A.

Res Immunol. 1995 Sep-Oct;146(7-8):539-45. Review. No abstract available. Erratum in: Res Immunol 1996 Feb;147(2):121.

PMID:
8839159
34.

IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.

Scharton-Kersten T, Afonso LC, Wysocka M, Trinchieri G, Scott P.

J Immunol. 1995 May 15;154(10):5320-30.

PMID:
7730635
35.

The role of the innate immune response in Th1 cell development following Leishmania major infection.

Scharton-Kersten T, Scott P.

J Leukoc Biol. 1995 Apr;57(4):515-22. Review.

PMID:
7722408

Supplemental Content

Loading ...
Support Center